OFTRIC – OZ
Power Against Mixed Infections
OFTRIC-OZ Tablets by Citric Labs combine Ofloxacin 200 mg and Ornidazole 500 mg to provide broad-spectrum antibacterial and antiprotozoal action. This combination is commonly prescribed for the treatment of mixed bacterial and protozoal infections, especially gastrointestinal, urinary, gynecological, and intra-abdominal infections. It helps eliminate infection-causing microorganisms while providing fast symptomatic relief when used as directed by a healthcare professional.
Composition
- Ofloxacin 200 mg
- Ornidazole 500 mg
Key Benefits
- Broad-spectrum antibacterial and antiprotozoal combination
- Helps treat mixed bacterial and parasitic infections
- Effective in gastrointestinal infections and infectious diarrhoea
- Supports faster recovery from intestinal infections
- Helps reduce abdominal pain, cramps, and loose motions associated with infections
- Manufactured under stringent quality standards
Product Description
OFTRIC-OZ Tablets contain Ofloxacin 200 mg and Ornidazole 500 mg, a broad-spectrum antibacterial and antiprotozoal combination used for the treatment of mixed bacterial and gastrointestinal infections. Manufactured by Citric Labs, a trusted name in PCD Pharma Franchise and quality pharmaceutical manufacturing.
Related products
Why Choose Citric Labs for PCD Pharma Franchise?
- High-quality WHO-GMP certified products
- Monopoly-based PCD Pharma Franchise opportunities
- Strong product portfolio including pain management range
- Competitive pricing & high margins
- Reliable supply chain across India
